|
1
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
2
|
Rivera C: The challenge of the state of
susceptibility to oral cancer. J Oral Res. 4:8–9. 2015.
|
|
3
|
van der Waal I: Potentially malignant
disorders of the oral and oropharyngeal mucosa; terminology,
classification and present concepts of management. Oral Oncol.
45:317–323. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mohajertehran F and Sahebkar A: The
promise of stem cell markers in the diagnosis and therapy of
epithelial dysplasia and oral squamous cell carcinoma. J Cell
Physiol. 233:8499–8507. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ranganathan K and Kavitha L: Oral
epithelial dysplasia: Classifications and clinical relevance in
risk assessment of oral potentially malignant disorders. J Oral
Maxillofac Pathol. 23:19–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaur J, Matta A, Kak I, Srivastava G, Assi
J, Leong I, Witterick I, Colgan TJ, Macmillan C, Siu KW, et al:
S100A7 overexpression is a predictive marker for high risk of
malignant transformation in oral dysplasia. Int J Cancer.
134:1379–1388. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stern C, Munn Z, Porritt K, Lockwood C,
Peters MDJ, Bellman S, Stephenson M and Jordan Z: An international
educational training course for conducting systematic reviews in
health care: The Joanna Briggs Institute's Comprehensive Systematic
Review Training Program. Worldviews Evid Based Nurs. 15:401–408.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ballman KV: Biomarker: Predictive or
prognostic? J Clin Oncol. 33:3968–3971. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rivera C, Oliveira AK, Costa RAP, De Rossi
T and Paes Leme AF: Prognostic biomarkers in oral squamous cell
carcinoma: A systematic review. Oral Oncol. 72:38–47.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mallett S, Timmer A, Sauerbrei W and
Altman DG: Reporting of prognostic studies of tumour markers: A
review of published articles in relation to REMARK guidelines. Br J
Cancer. 102:173–180. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ouzzani M, Hammady H, Fedorowicz Z and
Elmagarmid A: Rayyan-a web and mobile app for systematic reviews.
Syst Rev. 5(210)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Altman DG, McShane LM, Sauerbrei W and
Taube SE: Reporting recommendations for tumor marker prognostic
studies (REMARK): Explanation and elaboration. PLoS Med.
9(e1001216)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Feng JQ, Xu ZY, Shi LJ, Wu L, Liu W and
Zhou ZT: Expression of cancer stem cell markers ALDH1 and Bmi1 in
oral erythroplakia and the risk of oral cancer. J Oral Pathol Med.
42:148–153. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
de Vicente JC, Rodrigo JP,
Rodriguez-Santamarta T, Lequerica-Fernandez P, Allonca E and
Garcia-Pedrero JM: Podoplanin expression in oral leukoplakia:
Tumorigenic role. Oral Oncol. 49:598–603. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu
LQ and Zhou ZT: Expression patterns of cancer stem cell markers
ALDH1 and CD133 correlate with a high risk of malignant
transformation of oral leukoplakia. Int J Cancer. 132:868–874.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Connected Researchers. SciCurve: Revealing
life science's curves, 2014. Available from: http://connectedresearchers.com/tag/scicurve/.
Accessed November 16, 2018.
|
|
17
|
Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT
and Tang GY: Malignant transformation of oral leukoplakia: A
retrospective cohort study of 218 Chinese patients. BMC Cancer.
10(685)2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Taxy JB: Pathology of head and neck
neoplasms. UptoDate (online). Waltham, MA: UpToDate Inc. 2018
[cited 2018 10/25]. Available from: https://www.uptodate.com/contents/pathology-of-head-and-neck-neoplasms.
|
|
19
|
Rivera C: Opportunities for biomarkers
with potential clinical use in oral cancer. Medwave.
15(e6186)2015.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
20
|
Dunbar KB and Souza RF: Beyond dysplasia
grade: The role of biomarkers in stratifying risk. Gastrointest
Endosc Clin N Am. 27:447–459. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rebolj M, Helmerhorst T, Habbema D, Looman
C, Boer R, van Rosmalen J and van Ballegooijen M: Risk of cervical
cancer after completed post-treatment follow-up of cervical
intraepithelial neoplasia: Population based cohort study. BMJ.
345(e6855)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McCredie MR, Sharples KJ, Paul C, Baranyai
J, Medley G, Jones RW and Skegg DC: Natural history of cervical
neoplasia and risk of invasive cancer in women with cervical
intraepithelial neoplasia 3: A retrospective cohort study. Lancet
Oncol. 9:425–434. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang L, Lubpairee T, Laronde DM and Rosin
MP: Should severe epithelial dysplasia be treated? Oral Oncol.
60:125–129. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dissanayaka WL, Pitiyage G, Kumarasiri PV,
Liyanage RL, Dias KD and Tilakaratne WM: Clinical and
histopathologic parameters in survival of oral squamous cell
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 113:518–525.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tsai WC, Kung PT, Wang YH, Huang KH and
Liu SA: Influence of time interval from diagnosis to treatment on
survival for oral cavity cancer: A nationwide cohort study. PLoS
One. 12(e0175148)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tomita H, Tanaka K, Tanaka T and Hara A:
Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget.
7:11018–11032. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li X, Wan L, Geng J, Wu CL and Bai X:
Aldehyde dehydrogenase 1A1 possesses stem-like properties and
predicts lung cancer patient outcome. J Thorac Oncol. 7:1235–1245.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang L, Ren Y, Yu X, Qian F, Bian BS, Xiao
HL, Wang WG, Xu SL, Yang J, Cui W, et al: ALDH1A1 defines invasive
cancer stem-like cells and predicts poor prognosis in patients with
esophageal squamous cell carcinoma. Mod Pathol. 27:775–783.
2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Morimoto K, Kim SJ, Tanei T, Shimazu K,
Tanji Y, Taguchi T, Tamaki Y, Terada N and Noguchi S: Stem cell
marker aldehyde dehydrogenase 1-positive breast cancers are
characterized by negative estrogen receptor, positive human
epidermal growth factor receptor type 2, and high Ki67 expression.
Cancer Sci. 100:1062–1068. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
The Human Protein Atlas. ALDH1A1: Protein
expression overview [cited 2019 accessed 11 January 2019].
Available from: https://www.proteinatlas.org/ENSG00000165092-ALDH1A1/tissue.
|
|
31
|
Barzegar Behrooz A, Syahir A and Ahmad S:
CD133: Beyond a cancer stem cell biomarker. J Drug Target.
27:257–269. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Singer D, Thamm K, Zhuang H, Karbanová J,
Gao Y, Walker JV, Jin H, Wu X, Coveney CR, Marangoni P, et al:
Prominin-1 controls stem cell activation by orchestrating ciliary
dynamics. EMBO J. 38(e99845)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Krishnan H, Rayes J, Miyashita T, Ishii G,
Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, et
al: Podoplanin: An emerging cancer biomarker and therapeutic
target. Cancer Sci. 109:1292–1299. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cirligeriu L, Cimpean AM, Raica M and
Doros CI: Dual role of podoplanin in oral cancer development. In
Vivo. 28:341–347. 2014.PubMed/NCBI
|
|
35
|
Miyashita T, Higuchi Y, Kojima M, Ochiai A
and Ishii G: Single cell time-lapse analysis reveals that
podoplanin enhances cell survival and colony formation capacity of
squamous cell carcinoma cells. Sci Rep. 7(39971)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Saluja TS, Ali M, Mishra P, Kumar V and
Singh SK: Prognostic value of cancer stem cell markers in
potentially malignant disorders of oral mucosa: A meta-analysis.
Cancer Epidemiol Biomarkers Prev. 28:144–153. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Surendran S, Siddappa G, Mohan A, Hicks W
Jr, Jayaprakash V, Mimikos C, Mahri M, Almarzouki F, Morrell K,
Ravi R, et al: Cancer stem cell and its niche in malignant
progression of oral potentially malignant disorders. Oral Oncol.
75:140–147. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Koontongkaew S: The tumor microenvironment
contribution to development, growth, invasion and metastasis of
head and neck squamous cell carcinomas. J Cancer. 4:66–83.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Vargas-Ferreira F, Nedel F, Etges A, Gomes
AP, Furuse C and Tarquinio SB: Etiologic factors associated with
oral squamous cell carcinoma in non-smokers and non-alcoholic
drinkers: A brief approach. Braz Dent J. 23:586–590.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Faber J and Fonseca LM: How sample size
influences research outcomes. Dental Press J Orthod. 19:27–29.
2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Taylor JM, Ankerst DP and Andridge RR:
Validation of biomarker-based risk prediction models. Clin Cancer
Res. 14:5977–5983. 2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goossens N, Nakagawa S, Sun X and Hoshida
Y: Cancer biomarker discovery and validation. Transl Cancer Res.
4:256–269. 2015.PubMed/NCBI View Article : Google Scholar
|
